as on October 18, 2025 at 1:29 am IST
Day's Low
Day's High
1.11%
Downside
3.24%
Upside
52 Week's Low
52 Week's High
44.67%
Downside
47.87%
Upside
Check Agios Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.4B
EPS (TTM)
-7.4043
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
3.68
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
-456.3M
Revenue (TTM)
40.9M
Profit Margin
1590.42%
Return On Equity TTM
64.05%
Track how Agios Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Agios Pharmaceuticals, Inc. in the last 5 years
Lowest (-8.34x)
December 31, 2020
Today (3.68x)
October 18, 2025
Industry (8.36x)
October 18, 2025
Highest (2.47x)
June 30, 2021
Today’s Price to Earnings Ratio: 3.68x
Compare market cap, revenue, PE, and other key metrics of Agios Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $2.4B | 18.01% | 3.68 | 1590.42% | |
BUY | $63.1B | 231.27% | -505.15 | -12.96% | |
NA | $36.7B | NA | NA | -3.89% | |
BUY | $104.8B | 91.13% | 29.04 | 31.86% | |
BUY | $60.3B | -3.62% | 14.35 | 31.37% |
The Agios Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Agios Pharmaceuticals, Inc. investment value today
Current value as on today
₹97,805
Returns
Returns from Agios Pharmaceuticals, Inc. Stock
Dollar Returns*
₹4,794 (+4.79%)
Based on 15 analysts
73.33%
Buy
26.67%
Hold
0.00%
Sell
Based on 15 analysts, 73.33% of analysts recommend a 'BUY' rating for Agios Pharmaceuticals, Inc.. Average target price of $46.67
Get share price movements and forecasts by analysts on Agios Pharmaceuticals, Inc..
What analysts predicted
9.32%UPSIDE
Target Price
$46.67
Current Price
$42.32
Analyzed by
15 Analysts
Target
$46.67
Agios Pharmaceuticals, Inc. target price $46.67, a slight upside of 9.32% compared to current price of $42.32. According to 15 analysts rating.
Search interest for Agios Pharmaceuticals, Inc. Stock has decreased by -69% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 8.72M → 12.45M (in $), with an average increase of 29.9% per quarter
Price Rise
In the last 7 days, AGIO stock has moved up by 3.4%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 149.6% return, outperforming this stock by 87.7%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 69.8%
Profit Down
Netprofit is down for the last 2 quarters, -89.28M → -112.02M (in $), with an average decrease of 25.5% per quarter
Organisation | Agios Pharmaceuticals, Inc. |
Headquarters | 88 Sidney Street, Cambridge, MA, United States, 02139 |
Industry | Health Technology |
CEO | Mr. Brian M. Goff M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Brian M. Goff M.B.A. | CEO & Director |
Ms. Cecilia Jones | Chief Financial Officer |
Ms. Tsveta Milanova | Chief Commercial Officer |
Dr. Lewis clayton Cantley Ph.D. | Co-Founder |
Mr. James William Burns | Corporate Secretary & Chief Legal Officer |
Dr. Sarah Gheuens M.D., Ph.D. | Chief Medical Officer and Head of Research & Development |
Dr. Tak Wah Mak D.Sc., FRSC, Ph.D. | Co-Founder |
Dr. Craig B. Thompson M.D. | Co-Founder |
Dr. Shin-San Su Ph.D. | Co-Founder |
Mr. T. J. Washburn | VP, Controller & Principal Accounting Officer |
Agios Pharmaceuticals, Inc. share price today is $42.32 as on at the close of the market. Agios Pharmaceuticals, Inc. share today touched a day high of $43.69 and a low of $41.85.
Agios Pharmaceuticals, Inc. share touched a 52 week high of $62.58 on and a 52 week low of $23.42 on . Agios Pharmaceuticals, Inc. stock price today i.e. is closed at $42.32,which is 32.37% down from its 52 week high and 80.74% up from its 52 week low.
Agios Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Agios Pharmaceuticals, Inc. (AGIO) shares with as little as ₹87.954 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.54 in Agios Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Agios Pharmaceuticals, Inc. share’s latest price of $42.32 as on October 18, 2025 at 1:29 am IST, you will get 0.2363 shares of Agios Pharmaceuticals, Inc.. Learn more about
fractional shares .
Agios Pharmaceuticals, Inc. stock has given 18.01% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?